VEGFA and neoplasm: VEGF-A-induced myeloid-derived suppressor cells (MDSC) accumulation and T-cell decrease depend on VEGFR2 signaling as assessed by administration of two VEGF165 variants selectively targeting VEGFR1 or VEGFR2 to tumor-free mice [20].